Literature DB >> 26462195

2-Aminopyrimidines as dual adenosine A1/A2A antagonists.

Sarel J Robinson1, Jacobus P Petzer1, Gisella Terre'Blanche1, Anél Petzer2, Mietha M van der Walt2, Jacobus J Bergh1, Anna C U Lourens3.   

Abstract

In this study thirteen 2-aminopyrimidine derivatives were synthesised and screened as potential antagonists of adenosine A1 and A2A receptors in order to further investigate the structure activity relationships of this class of compounds. 4-(5-Methylfuran-2-yl)-6-[3-(piperidine-1-carbonyl)phenyl]pyrimidin-2-amine (8m) was identified as a compound with high affinities for both receptors, with an A2AKi value of 6.34 nM and an A1Ki value of 9.54 nM. The effect of selected compounds on the viability of cultured cells was assessed and preliminary results indicate low cytotoxicity. In vivo efficacy at A2A receptors was illustrated for compounds 8k and 8m since these compounds attenuated haloperidol-induced catalepsy in rats. A molecular docking study revealed that the interactions between the synthesised compounds and the adenosine A2A binding site most likely involve Phe168 and Asn253, interactions which are similar for structurally related adenosine A2A receptor antagonists.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  2-Aminopyrimidine; Adenosine A(1) antagonist; Adenosine A(2A) antagonist; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 26462195     DOI: 10.1016/j.ejmech.2015.09.035

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A1 receptors for the potential treatment of epilepsy.

Authors:  Gaofenngwe Nkomba; Gisella Terre'Blanche; Helena D Janse van Rensburg; Lesetja J Legoabe
Journal:  Med Chem Res       Date:  2022-05-24       Impact factor: 2.351

Review 2.  Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.

Authors:  Werner J Geldenhuys; Ahmad Hanif; June Yun; Mohammed A Nayeem
Journal:  Molecules       Date:  2017-06-01       Impact factor: 4.411

3.  C3 amino-substituted chalcone derivative with selective adenosine rA1 receptor affinity in the micromolar range.

Authors:  Helena D Janse van Rensburg; Lesetja J Legoabe; Gisella Terre'Blanche
Journal:  Chem Zvesti       Date:  2020-11-17       Impact factor: 2.097

4.  Hybrides of Alkaloid Lappaconitine with Pyrimidine Motif on the Anthranilic Acid Moiety: Design, Synthesis, and Investigation of Antinociceptive Potency.

Authors:  Kirill P Cheremnykh; Victor A Savelyev; Sergey A Borisov; Igor D Ivanov; Dmitry S Baev; Tatyana G Tolstikova; Valentin A Vavilin; Elvira E Shults
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

5.  Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.

Authors:  Mukuo Wang; Shujing Hou; Yu Wei; Dongmei Li; Jianping Lin
Journal:  PLoS Comput Biol       Date:  2021-03-19       Impact factor: 4.475

6.  Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.

Authors:  Pierre Koch; Andreas Brunschweiger; Vigneshwaran Namasivayam; Stefan Ullrich; Annalisa Maruca; Beatrice Lazzaretto; Petra Küppers; Sonja Hinz; Jörg Hockemeyer; Michael Wiese; Jag Heer; Stefano Alcaro; Katarzyna Kiec-Kononowicz; Christa E Müller
Journal:  Front Chem       Date:  2018-06-26       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.